by admin | Dec 19, 2018 | Encore Vision, News
Novartis has revealed how much it paid to buy Encore Vision, a Fort Worth startup that has developed an eyedrop to treat presbyopia — and it’s an eye-opener. In an SEC filing Wednesday, the Swiss pharmaceutical giant that owns Alcon put the preliminary fair value of...
by admin | Feb 1, 2017 | Encore Vision, News
Big winners in Novartis AG’s acquisition of Encore Vision for $465 million are members of a network of angel investors in Fort Worth, TX, that bet $4 million on the presbyopia-correcting eye drop that Encore Vision president and CEO Bill Burns has been working on for...
by admin | Dec 20, 2016 | Encore Vision, News
Fort Worth-based eye care firm Encore Vision Inc. is being acquired by Swiss drugmaker Novartis, the company announced today.Encore Vision has developed a topical treatment for presbyopia patients, or people with far-sightedness. It is estimated that more than 80...